🔴 LIVE — Updated every 10 minutes
👤 -- reading now 🌡 Nairobi
Breaking
HomeFinanceHow ‘Ozempic face’ is pushing Gen…
Finance

How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early

Fortune Jun 24, 2026 2h ago ⏱ 1 min read 👁 1 views
How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
Image via Fortune
📋 Article Summary
46 words
“I just started to feel like I was seeing more lines around my eyes or something, and thought I would just go check out this doctor," one Gen Xer said. This story was reported by Fortune. For more Finance news in Kenya, stay tuned to Masaa.
Continue Reading
Full story on Fortune
Read Full Story →
🔗 Clicking will take you to fortune.com
Share this story: WhatsApp X/Twitter Facebook
👁 People Also Read
North Sea Crude Weakens as Mideast Oil Floods Back to Market
Finance

North Sea Crude Weakens as Mideast Oil Floods Back to Market

Key indicators in the North Sea crude market are showing signs of weakness as a wave of Middle Eastern oil…

Read
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
Finance

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup

It wasn’t thousands of staff petitioning to work from home or the Iran war that convinced CEOs to loosen their…

Read
‘Looking Over Our Shoulder:’ Traders Are Loading Up on VIX Calls
Finance

‘Looking Over Our Shoulder:’ Traders Are Loading Up on VIX Calls

Summer is officially here for US stock traders. Recession odds aren’t alarming. The US and Iran are negotiating. Corporate America’s…

Read
Investor Who Scored 900% Win in 2008 Crisis Has New Big Short Bet
Finance

Investor Who Scored 900% Win in 2008 Crisis Has New Big Short Bet

Hedge fund manager Lee Robinson notched a 900% gain during the global financial crisis by turning a $20 million position…

Read